PNC FINANCIAL SERVICES GROUP, INC. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.8%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$0
-100.0%
1,2000.0%0.00%
Q3 2018$1,0000.0%1,2000.0%0.00%
Q2 2018$1,000
-66.7%
1,2000.0%0.00%
Q1 2018$3,0000.0%1,2000.0%0.00%
Q4 2017$3,000
-50.0%
1,200
-45.5%
0.00%
Q3 2017$6,000
+20.0%
2,2000.0%0.00%
Q2 2017$5,000
-37.5%
2,2000.0%0.00%
Q1 2017$8,000
-27.3%
2,200
-26.7%
0.00%
Q4 2016$11,000
-84.5%
3,000
-82.9%
0.00%
Q3 2016$71,000
-10.1%
17,500
-3.0%
0.00%
Q2 2016$79,000
+12.9%
18,040
-2.3%
0.00%
Q1 2016$70,000
-66.8%
18,461
+37.1%
0.00%
Q4 2015$211,000
+62.3%
13,469
+9.1%
0.00%
Q3 2015$130,000
-60.7%
12,342
-6.0%
0.00%
Q2 2015$331,000
-7.5%
13,124
+2.1%
0.00%
Q1 2015$358,000
+53.6%
12,855
+0.8%
0.00%
Q4 2014$233,000
+43.8%
12,750
+2.0%
0.00%
Q3 2014$162,000
-20.6%
12,5000.0%0.00%
Q2 2014$204,000
+0.5%
12,500
+8.7%
0.00%
Q1 2014$203,000
-27.0%
11,5000.0%0.00%
Q4 2013$278,000
-31.7%
11,5000.0%0.00%
-100.0%
Q3 2013$407,000
+640.0%
11,500
+228.6%
0.00%
Q2 2013$55,0003,5000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders